Albemarle (ALB) PT Lowered to $88 at Buckingham Research

Go back to Albemarle (ALB) PT Lowered to $88 at Buckingham Research

Albemarle (ALB) Preannounces Shipment Delay, PT Cut To $100 At RBC

March 29, 2019 6:13 AM EDT

RBC Capital analyst, Arun Viswanathan, reiterated his Outperform on Albemarle (NYSE: ALB) but cut the price target to $100.00 (from $113.00) after the company preannounced negatively statring 1Q19 EBITDA will be ~$1518M lower and EPS will be $1.201.25 due to ~33.5kT of LCE volume shifting to subsequent... More

Albemarle (ALB) Expects Lithium Volume Shift from Q1 but Reaffirms Full Year Guidance

March 28, 2019 4:29 PM EDT

Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that... More